Multiple Myeloma Research Foundation Holds First Patient Summit in Denver
The first-ever Multiple Myeloma Research Foundation (MMRF)…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
New Cancer Drug-delivery Vehicle May Provide More Precise Treatment, Study Shows
Antibody-drug conjugates (ADCs), a class of drugs in which…
BioLineRx’s BL-8040 Shows Promise in Bone Marrow Transplants for Blood Cancers
BioLineRx’s investigational drug BL-8040 has demonstrated positive interim results from…
Experimental LCL161 Combo Therapy Boosts Immunity and Shrinks Tumors in Myeloma Patients
By activating the immune system, the experimental drug LCL161…
Myeloma UK Launches Reolysin Combo Trial for Relapsing Myeloma Patients
The cancer charity Myeloma UK has launched a Phase 1…
Patient Power Backs Multiple Myeloma Patient’s Quest to Run 101st Marathon
Don Wright, who recently finished his 100th marathon while…
